Pramodini Medicare
Key Fundamentals
SMEHealthcare ServicesHealthcarePrice-based figures as of · TTM
- ROCE
- 41.80%
- Debt to Equity
- 0.34
- EPS (TTM)
- —
- Book Value
- ₹52.75
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 2.09
- ROE
- 39.10%
- Dividend Yield
- 0.00%
- EBITDA
- ₹32.00 Cr
- 52W High
- ₹137.00
- 52W Low
- ₹104.00
- Volume
- 0
Peer Comparison
Healthcare › Healthcare Services › Healthcare Service Provider
| ₹2,029.40 | 62.75 | ₹32,036 Cr | 13.58 | 0.26% | 22.30% | 28.00% | ₹2,891 Cr | ₹545 Cr | |
| ₹1,424.60 | 78.15 | ₹14,588 Cr | 15.33 | 0.14% | 18.30% | 20.50% | ₹857 Cr | ₹187 Cr | |
| ₹581.25 | 59.74 | ₹11,437 Cr | 8.03 | 0.88% | 13.60% | 17.80% | ₹1,710 Cr | ₹203 Cr | |
| ₹495.50 | 44.72 | ₹7,723 Cr | 14.25 | 2.90% | 28.40% | 35.40% | ₹876 Cr | ₹176 Cr | |
| ₹622.35 | 148.53 | ₹5,903 Cr | 5.61 | 0.00% | 8.83% | 15.30% | ₹1,053 Cr | ₹85 Cr | |
| ₹333.05 | 48.41 | ₹1,717 Cr | 7.08 | 0.15% | 14.20% | 17.30% | ₹325 Cr | ₹35 Cr | |
| ₹483.05 | 15.84 | ₹1,571 Cr | 1.51 | 0.41% | 10.90% | 12.70% | ₹726 Cr | ₹98 Cr | |
| Pramodini Medicare (this company) | ₹110.00 | — | ₹238 Cr | 2.09 | 0.00% | 39.10% | 41.80% | — | — |
| Median 8 companies | ₹538.38 | 59.74 | ₹6,813 Cr | 7.56 | 0.21% | 16.25% | 19.15% | ₹876 Cr | ₹176 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Key Insights
Strengths
2- Company has a good return on equity (ROE) track record: 3 Years ROE 36.4%
- Debtor days have improved from 131 to 102 days.
No weaknesses listed
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 7 | 10 | 2 |
| Oscillators | Bearish | 3 | 6 | 0 |
| Moving Averages | Bearish | 4 | 4 | 2 |
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bearish
Key readings
- RSI (14)
- 45.60
- Neutral
- MACD (12,26,9)
- −2.35
- Bearish
- SMA (50)
- 115.43
- Bearish
- SMA (200)
- —
- Neutral
As of
Growth Rate
From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 3Y | +25.99% |
|---|---|
| 1Y | +63.16% |
Net profit
| 3Y | +41.50% |
|---|---|
| 1Y | +54.55% |
Operating cash flow
| 3Y | +27.72% |
|---|---|
| 1Y | +13.64% |
Operating margin· change in pp
| 3Y | +1.61 pp |
|---|---|
| 1Y | −5.26 pp |
Trailing twelve months: No quarterly results are reported.
Revenue by year
| Mar 2022 | ₹25.00 Cr |
|---|---|
| Mar 2023 | ₹31.00 Cr |
| Mar 2024 | ₹35.00 Cr |
| Mar 2025 | ₹38.00 Cr |
| Mar 2026 | ₹62.00 Cr |
Net profit by year
| Mar 2022 | ₹5.00 Cr |
|---|---|
| Mar 2023 | ₹6.00 Cr |
| Mar 2024 | ₹7.00 Cr |
| Mar 2025 | ₹11.00 Cr |
| Mar 2026 | ₹17.00 Cr |
Profit & Loss
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 25 | 31 | 35 | 38 | 62 |
| Expenses | 13 | 16 | 20 | 17 | 31 |
| Operating Profit | 12 | 15 | 16 | 21 | 31 |
| OPM % | 49% | 49% | 44% | 55% | 50% |
| Other Income | 0 | 0 | 1 | 0 | 1 |
| Interest | 2 | 2 | 2 | 1 | 1 |
| Depreciation | 4 | 5 | 4 | 4 | 7 |
| PBT | 7 | 8 | 10 | 16 | 23 |
| Tax % | 29% | 27% | 29% | 29% | 25% |
| Net Profit | 5 | 6 | 7 | 11 | 17 |
| EPS (₹) | 4.92 | 4.76 | 5.4 | 85.89 | 10.41 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 17 |
| Reserves | 10 | 18 | 23 | 34 | 36 |
| Borrowings | 25 | 21 | 12 | 11 | 18 |
| Other Liabilities | 6 | 9 | 12 | 10 | 23 |
| Total Liabilities | 41 | 50 | 49 | 56 | 94 |
| Fixed Assets | 26 | 22 | 16 | 22 | 44 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 15 | 27 | 33 | 35 | 49 |
| Total Assets | 41 | 50 | 49 | 56 | 94 |
Cash Flow
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 12 | 12 | 10 | 22 | 25 |
| Investing | −12 | −12 | −1 | −15 | −31 |
| Financing | 3 | 3 | −11 | −2 | 6 |
| Net Cash Flow | 3 | 3 | −2 | 5 | 0 |
| Free Cash Flow | 0 | 0 | 9 | 12 | −4 |
| CFO/OP | 113 | 93 | 83 | 127 | 98 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 109 | 172 | 186 | 107 | 102 |
| Cash Conversion Cycle | 109 | 172 | 186 | 107 | 102 |
| Working Capital Days | −66 | −36 | 16 | 0 | 2 |
| ROCE % | — | 27% | 30% | 41% | 42% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Pramodini Medicare insights
28 extracted metrics across FY22–FY26.
Documents
- 7 Oct 2026
- 7 Oct 2026
- 1 Oct 2026
- 1 Oct 2026
- 1 Oct 2026
Frequently Asked Questions about Pramodini Medicare
What does Pramodini Medicare Ltd do?
Where is Pramodini Medicare Ltd (PRAMODINI) listed?
Which sector does Pramodini Medicare Ltd belong to?
What is the 52-week high and low of Pramodini Medicare Ltd?
What is the Return on Equity (ROE) of Pramodini Medicare Ltd?
Company Information
Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PRAMODINI.md for Pramodini Medicare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.